Comparative Evaluation of Biodentine and Bioceramic as Pulp Medicaments Following Laser and Conventional Pulpotomy in Primary Molars: A Double-blind Randomized Controlled Trial

Aim: The purpose of this randomized controlled trial was to evaluate and compare the clinical and radiographic success of Biodentine and Bioceramic putty as pulp medicaments following diode laser-assisted and conventional pulpotomy in primary molars. Materials and Methods: Forty-eight primary molars in children aged 4–9 years were randomly assigned into four groups ( n = 12 each): Conventional pulpotomy with Biodentine, conventional pulpotomy with Bioceramic, laser-assisted pulpotomy with Biodentine, and laser-assisted pulpotomy with Bioceramic. Clinical and radiographic outcomes were evaluated at 1, 3, and 6 months using Zurn and Seale criteria (2008). Data were analyzed with one-way ANOVA, with significance set at P < 0.05. Results: All groups showed favorable clinical and radiographic success at 6 months. The laser–Bioceramic group demonstrated the highest overall success (83.2%), followed by laser–Biodentine (75%) and conventional Bioceramic (75%), whereas conventional Biodentine showed comparatively lower success (50%). Differences among groups were not statistically significant ( P > 0.05). Conclusions: Both Biodentine and Bioceramic were effective pulpotomy medicaments in primary molars, with Bioceramic showing slightly better outcomes. Laser-assisted pulpotomy provided additional clinical benefits, particularly in enhancing hemostasis and healing, although the differences were not statistically significant.